GlassScriptPhysician profile
Beth D Carney
NPI 1811973118
$1,428.24
in general payments reported to CMS, 2019-2025
21 companies · $326 in 2025
The $326 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $328 · 2022: $30.19 · 2023: $327 · 2024: $418 · 2025: $326.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,071.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,070.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aspira Women'S Health INC | $263.59 | 2021-2024 | Ova1 |
| Astellas Pharma US INC | $221.01 | 2023-2025 | Veozah, Myrbetriq |
| Sumitomo Pharma America, INC. | $187.72 | 2023-2025 | Myfembree |
| Abbvie INC. | $121.68 | 2022-2025 | |
| Mayne Pharma Commercial LLC | $92.54 | 2023-2025 | |
| Sage Therapeutics, LLC | $84.99 | 2024-2025 | Zurzuvae |
| Evofem Biosciences, INC. | $73.00 | 2023-2025 | Phexxi, Solosec, Phexx |
| Coopersurgical, INC. | $69.28 | 2023-2025 | Paragard T 380a, Paragard T 380a |
| Pfizer INC. | $47.71 | 2021-2023 | |
| Myovant Sciences INC. | $31.82 | 2021 | |
| Boston Scientific Corporation | $26.14 | 2024 | Watchman Flx |
| Millicent US INC | $24.93 | 2025 | Intrarosa, Femlyv |
| Mylan Pharmaceuticals INC. | $24.46 | 2021 | |
| Exact Sciences Corporation | $24.41 | 2024 | Cologuard Collection Kit |
| Supernus Pharmaceuticals, INC. | $21.93 | 2025 | Qelbree |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $21.67 | 2024 | Voquezna |
| Organon LLC | $21.34 | 2023 | Nexplanon |
| Hologic Sales and Service, LLC | $19.51 | 2023 | Aptima, Affirm Prone Biopsy System |
| Merck Sharp & Dohme LLC | $19.08 | 2024 | Gardasil 9, Gardasil |
| Shield Therapeutics INC | $17.99 | 2024 | |
| Exeltis, USA INC. | $13.44 | 2024 | Slynd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beth Carney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.